Kimura

Doxazosin mesilate, the active ingredient in Kimura, is an alpha‑1 adrenergic blocker presented as an oral tablet for systemic use. It lowers elevated blood pressure and relaxes smooth muscle in the prostate, helping manage hypertension and benign prostatic hyperplasia in adult patients.

GNH USA supplies Kimura as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across EU and other markets.

Doxazosin mesilate is used to treat conditions related to vascular tone and prostate smooth‑muscle tone.

Hypertension: reduces systemic blood pressure by vasodilation. Benign prostatic hyperplasia (BPH): improves urinary flow by relaxing prostatic smooth muscle. Lower urinary tract symptoms associated with BPH: alleviates urgency and frequency.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially when standing quickly. - Headache: mild to moderate pressure or throbbing pain. - Fatigue: generalized tiredness without exertion.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Priapism: prolonged, painful erection requiring urgent care. - Angioedema: swelling of face, lips, tongue or throat that can impair breathing.

Before initiating therapy, consider the following precautions: - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Hepatic impairment: dose may need adjustment in patients with liver dysfunction. - Orthostatic hypotension: advise patients to rise slowly from sitting or lying positions. - Concomitant antihypertensives: assess for additive blood‑pressure‑lowering effects. - Hypersensitivity: discontinue if signs of allergic reaction appear. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Doxazosin mesilate may interact with several drug classes.

Major Interactions (Avoid): - Other antihypertensives (e.g., ACE inhibitors, diuretics): risk of additive hypotension. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase plasma concentrations. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause severe hypotension.

Moderate Interactions (Monitor Closely):\n- NSAIDs: may blunt antihypertensive effect. - Beta‑blockers: can mask tachycardia from hypotension. - Alcohol: may enhance dizziness and blood‑pressure lowering.